Table 3.

(a) Echocardiographic outcomes, (b) Procedural outcomes

	Overall, N = 46	BAV, N = 31	SAV, N = 15
(a)
Mitral valve mean gradient, mmHg	5.78 (2.38)	6.40 (2.04)	4.23 (2.55)
Transvalvular gradient, mmHg	27/(64%)	23/(77%)	4/(33%)
Left ventricular end-diastolic diameter, cm	5.10 (0.76)	5.01 (0.75)	5.33 (0.79)
Pulmonary artery systolic pressure, mmHg	51.00 (38.00, 57.00)	52.00 (39.00, 57.00)	46.50 (38.25, 54.25)
Paravalvular regurgitation at discharge
Severe	1/(2.3%)	0/(0%)	1/(7.7%)
Moderate	1/(2.3%)	1/(3.3%)	0/(0%)
Mild	6/(14%)	5/(17%)	1/(7.7%)
None-trace	35/(81%)	24/(80%)	11/(85%)
Paravalvular regurgitation at 30 days (n = 36)
Severe	1/(2.8%)	0/(0%)	1/(10%)
Moderate	1/(2.8%)	1/(3.8%)	0/(0%)
Mild	5/(14%)	4/(15%)	1/(10%)
None-trace	29/(81%)	21/(81%)	8/(80%)

	Overall, N = 46	BAV, N = 31	SAV, N = 15
(b)
Conversion to open surgery	1/(2.2%)	1/(3.2%)	0/(0%)
Bleeding
None	35/(76%)	27/(87%)	8/(53%)
Minor bleeding	1/(2.2%)	0/(0%)	1/(6.7%)
Major bleeding	5/(11%)	2/(6.5%)	3/(20%)
Life-threatening-bleeding	5/(11%)	2/(6.5%)	3/(20%)
Vascular access complication
None	36/(78%)	25/(81%)	11/(73%)
Minor access complication	4/(8.7%)	3/(9.7%)	1/(6.7%)
Major access complication	6/(13%)	3/(9.7%)	3/(20%)
Rhythm at discharge
Sinusrhythm	22/(48%)	16/(52%)	6/(40%)
Atrial fibrillation	12/(26%)	7/(23%)	5/(33%)
Pacemaker	12/(26%)	8/(26%)	4/(27%)
Acute kidney injury requiring hemodialysis	4/(15%)	1/(8.3%)	3/(20%)
New permanent pacemaker requirement	0/(0%)	0/(0%)	0/(0%)
New stroke	1/(2.2%)	1/(3.2%)	0/(0%)
In-hospital mortality	5/(11%)	2/(6.5%)	3/(20%)
Intensive care unit stay, days	2.00 (1.00, 5.00)	2.00 (1.00, 4.00)	2.00 (1.50, 5.50)
Total hospital stay, days	13.00 (8.00, 17.75)	10.00 (7.50, 15.50)	16.00 (11.00, 18.50)

Values are reported as mean ± SD for parametric variables, median (interquartile range) for nonparametric continuous variables, and n (%) for categorical variables, BAV balloon-expandable valve, MAC mitral annular calcification, SAV self-expanding valve